About: Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
Creator	Arvat, · Badalamenti, · Baldari, · Bartolomei, · Brizzi, · Campana, · Cingarlini, · Cives, · De Carlo, · Faggiano, · Falconi, · Fanciulli, · Ferolla, · Ferone, · Gelsomino, · Grana, · Maccauro, · Massironi, · Merola, · Modica, · Panzuto, F Pusceddu, · Rinzivillo, · Spada, · Tafuto, · Versari, · Zatelli, ·
Source	Medline; PMC
abstract	INTRODUCTION: The organization of the healthcare system has significantly changed after the recent COVID-19 outbreak, with a negative impact on the management of oncological patients. The present survey reports data collected by the Italian Association for Neuroendocrine Tumors on the management of patients with neuroendocrine neoplasia (NEN) during the pandemic dissemination. METHODS: A survey with 57 questions was sent to NEN-dedicated Italian centers regarding the management of patients in the period March 9, 2020, to May 9, 2020 RESULTS: The main modification in the centers’ activity consisted of decreases in newly diagnosed NEN patients (− 76.8%), decreases in performed surgical procedures (− 58%), delays to starting peptide receptor radionuclide therapy (45.5%), postponed/canceled follow-up examinations (26%), and canceled multidisciplinary teams’ activity (20.8%). A low proportion of centers (< 10%) reported having to withdraw systemic anti-tumor medical treatment due to concerns about the pandemic situation, whereas PRRT was withdrawn from no patients. CONCLUSION: Although the COVID-19 outbreak induced the centers to reduce some important activities in the management of NEN patients, the Italian network was able to provide continuity in care without withdrawing anti-tumor treatment for the majority of patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40618-020-01393-4) contains supplementary material, which is available to authorized users.
has issue date	2020-08-16(xsd:dateTime)
bibo:doi	10.1007/s40618-020-01393-4
bibo:pmid	32803662
has license	no-cc
sha1sum (hex)	444fa1c479752586101e669b9a83b2ed32c88c03
schema:url	https://doi.org/10.1007/s40618-020-01393-4
resource representing a document's title	Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
has PubMed Central identifier	PMC7429140
has PubMed identifier	32803662
schema:publication	J Endocrinol Invest
resource representing a document's body	covid:444fa1c479752586101e669b9a83b2ed32c88c03#body_text
is schema:about of	named entity 'multidisciplinary teams' named entity 'patients' named entity 'REPORTS' named entity 'SENT' named entity 'PANDEMIC' named entity 'CENTERS' named entity 'PATIENTS' named entity 'STARTING' named entity 'NEGATIVE' named entity 'LOW' named entity 'NETWORK' named entity 'SYSTEMIC' named entity 'CHANGED' named entity 'surgical procedures' named entity 'The organization' named entity 'Association' named entity 'provide' named entity 'medical treatment' named entity 'reduce' named entity 'performed' named entity 'canceled' named entity 'surgical procedures' named entity 'Italian' named entity 'COVID-19 outbreak' named entity 'PRRT' named entity 'NEN' named entity 'Italian' named entity 'NEN' named entity 'neoplasia' named entity 'anti-tumor' named entity 'Italy' named entity 'NEN' named entity 'email' named entity 'multidisciplinary teams' named entity 'oncological' named entity 'SurveyMonkey' named entity 'PRRT' named entity 'peptide receptor radionuclide therapy' named entity 'NEN' named entity 'PRRT' named entity 'NEN' named entity 'SurveyMonkey' named entity 'NEN' named entity 'NEN' named entity 'medical treatments' named entity 'NEN' named entity 'Italy' named entity 'Italian' named entity 'NEN' named entity 'NEN' named entity 'surgeon' named entity 'medical treatments' named entity 'PRRT' named entity 'NEN' named entity 'surgical procedures'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software